The novel approach of the medication represents a significant breakthrough in the management of the condition. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide925628.bluxeblog.com/74479223/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment